Dare Bioscience Inc. (DARE)
NASDAQ · Healthcare
Dare Bioscience Inc. Operating Income 2012–2025
Dare Bioscience Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Dare Bioscience Inc. operating income for the quarter ending March 31, 2026 was -3.0 M, a 34.54% decrease year-over-year.
- Dare Bioscience Inc. operating income for the twelve months ending March 31, 2026 was -15.9 M, a 48.21% decrease year-over-year.
- Dare Bioscience Inc. annual operating income for 2025 was -13.6 M, a 42.21% decrease from 2024.
- Dare Bioscience Inc. annual operating income for 2024 was -23.5 M, a 24.20% decrease from 2023.
- Dare Bioscience Inc. annual operating income for 2023 was -30.9 M, a 1.42% decrease from 2022.
- Dare Bioscience Inc. annual operating income for 2022 was -31.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Dare Bioscience Inc. Operating Income — FAQ
Dare Bioscience Inc. (DARE) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Dare Bioscience Inc.'s operating income?
Dare Bioscience Inc. (DARE) reported operating income of -$14M for fiscal 2025.
Where can I see DARE's operating income history?
The chart and table above show Dare Bioscience Inc.'s operating income by year and by quarter, including the growth rate.